# Imiquimod for Preventing Keloid Recurrence

> **NCT03760250** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 6 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Imiquimod 5% cream

## Key facts

- **NCT ID:** NCT03760250
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-05
- **Primary completion:** 2019-09-05
- **Final completion:** 2020-09-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Investigator decision
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760250, "Imiquimod for Preventing Keloid Recurrence". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03760250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*